Slide 1: 2nd Quarter 2025 Earnings Release
07.24.25 nd 2 Quarter 2025 Earnings Release Supplemental Information
Slide 2: Safe Harbor
Safe Harbor Forward Looking Statements This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, such as statements about our future plans, objectives, expectations, financial performa
Slide 3: Q2 2025 Year-Over-Year
Q2 2025 YEAR-OVER-YEAR Second Quarter Revenue Non-GAAP Diluted EPS* Net Cash Provided by ($M) ($) Operating Activities Results above ($M) expectations • Revenue exceeded the high 0.24 end of our guided range. 145.9 0.20 • Non-GAAP Diluted EPS was 135.2 24.9 above the mid-point of our guided range. 3
Slide 4: Q2 2025 Segment Performance: MedTech & Specialty Audio
Q2 2025 SEGMENT PERFORMANCE Revenue Adjusted EBITDA Margin* ($M) (%) MedTech & Specialty Audio 44.4 67.4 42.0 61.1 • Revenue grew year over year on higher demand in specialty audio. • Adjusted EBITDA margins were down 240 bps year over year driven by unfavorable product mix. -240 +10.3% bps • As exp
Slide 5: Q2 2025 Segment Performance: Precision Devices
Q2 2025 SEGMENT PERFORMANCE Revenue Adjusted EBITDA Margin* ($M) (%) Precision Devices 20.8 78.5 19.4 74.1 • Revenue was up year over year with strong demand and design wins across all our end markets; Medtech, Defense, and Industrial. • Adjusted EBITDA margins were up year over year driven by highe
Slide 6: Outlook
OUTLOOK Q3 2025 Guidance GAAP Adjustments Non-GAAP Revenues from continuing operations $144 to $154 million $— $144 to $154 million Diluted earnings per share from $0.18 to $0.22 $0.11 $0.29 to $0.33 continuing operations Net cash provided by operating activities $20 to $30 million $— $20 to $30 mil
Slide 7: Appendix
« knowles Appendix
Slide 8: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES Quarter Ended June 30, (continuing operations, in millions, except per share amounts) 2025 2024 Revenues $ 145.9 $ 135.2 Notes Gross profit $ 60.6 $ 57.8 1. Production transfer costs represent duplicate costs incurred to migrat
Slide 9: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES Quarter Ended June 30, (continuing operations, in millions, except per share amounts) 2025 2024 Notes Net earnings $ 7.8 $ 4.8 5. The non-GAAP reconciling adjustments to reconcile Earnings before interest and Interest expense,
Slide 10: Historical Segment Data
HISTORICAL SEGMENT DATA PRECISION DEVICES MEDTECH & SPECIALTY AUDIO Quarter Ended Quarter Ended June 30, March 31, December 31, September 30, June 30, June 30, March 31, December 31, September 30, June 30, (continuing operations, in millions) 2025 2025 2024 2024 2024 2025 2025 2024 2024 2024 Revenue
Slide 11: Historical Segment Data
HISTORICAL SEGMENT DATA PRECISION DEVICES MEDTECH & SPECIALTY AUDIO Quarter Ended Quarter Ended June 30, March 31, December 31, September 30, June 30, June 30, March 31, December 31, September 30, June 30, (continuing operations, in millions) 2025 2025 2024 2024 2024 2025 2025 2024 2024 2024 Revenue
Slide 12: Quarter Ended
Quarter Ended June 30, March 31, December 31, September 30, June 30, March 31, December 31, September 30, June 30, March 31, (Continuing operations, in millions) 2025 2025 2024 2024 2024 2024 2023 2023 2023 2023 Net earnings (loss) $ 7.8 $ (0.4) $ 10.4 $ 9.2 $ 4.8 $ (1.0) $ 26.6 $ 15.2 $ 17.6 $ 6.2
Slide 13: Quarter Ended
Quarter Ended June 30, March 31, December 31, September 30, Trailing (Continuing operations, in millions) 2025 2025 2024 2024 12-months Net earnings (loss) $ 7.8 $ (0.4) $ 10.4 $ 9.2 $ 27.0 Interest expense, net 2.5 2.7 3.4 3.9 12.5 Provision for income taxes 3.5 1.2 3.3 3.0 11.0 Earnings before int
Slide 14: Reconciliation of Net Debt
RECONCILIATION OF NET DEBT (in millions) June 30, 2025 Current maturities of long-term debt $ 71.0 Long-term debt 119.0 Total debt 190.0 Less: Cash and cash equivalents (103.2) Net debt $ 86.8 Net debt $ 86.8 Trailing 12 Month Adjusted EBITDA $ 129.1 Net debt leverage ratio 0.7 x 14
Slide 15: Thank you.
Thank you. « knowles